Drug
11c Orm 13070
11c Orm 13070: highest development phase Phase 1, developed by Orion Corporation. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Orion Corporation
Trials
| Drug | Phase | Indication |
|---|---|---|
| 11C-ORM-13070 NCT00735774 | Phase 1 | Healthy |
Latest
No recent events.
Follow 11c Orm 13070 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.